Journal Menu
► ▼ Journal Menu-
- Antibodies Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
21 November 2022
Editorial Board Members from Antibodies Featured in Stanford’s List of the World’s Top 2% Scientists
Stanford University has recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.
The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: “Lifetime Scientific Influence Ranking” and “2022 Annual Scientific Influence Ranking”. The “Lifetime Scientific Influence Ranking” measures the comprehensive influence performance of scientists during their careers, and the “2022 Annual Influence Ranking” focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered to be the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database, and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.
We are pleased to share that 21 Editorial Board Members from MDPI’s Antibodies (ISSN: 2073-4468) were featured in Stanford University’s list of the World’s Top 2% Scientists in 2022.
|
Name |
Affiliation |
|
Prof. Dr. John C. Cambier |
University of Colorado Denver School of Medicine and National Jewish Health, USA |
|
Prof. Dr. Fabienne Mackay |
QIMR Berghofer Medical Research Institute in Brisbane QLD, Australia |
|
Prof. Dr. Fabio Malavasi |
University of Turin and Fondazione Ricerca Molinette, Italy |
|
Dr. Gestur Vidarsson |
University of Amsterdam, The Netherlands |
|
Dr. Guglielmo Lucchese |
Universitätsmedizin Greifswald, Germany |
|
Dr. Iftekhar Mahmood |
Mahmood Clinical Pharmacology, Consultancy, LLC, USA |
|
Prof. Dr. Chaim O. Jacob |
University of Southern California, USA |
|
Prof. Dr. Jagadeesh Bayry |
National Institute for Health and Medical Research (INSERM), France |
|
Dr. Wei Li |
University of Pittsburgh, USA |
|
Prof. Dr. Buyong Ma |
Shanghai Jiaotong University, China |
|
Prof. Dr. Michael G. Weller |
Federal Institute for Materials Research and Testing (BAM), Germany |
|
Prof. Dr. Nick Devoogdt |
Vrije Universiteit Brussel, Belgium |
|
Prof. Dr. Qi Zhao |
University of Macau, China |
|
Prof. Dr. Raphael Clynes |
Columbia University College of Physicians and Surgeons, USA |
|
Prof. Dr. Roland Kontermann |
University of Stuttgart, Germany |
|
Prof. Dr. Serge Muyldermans |
Vrije Universiteit Brussel, Belgium |
|
Prof. Dr. Yukihiro Shoyama |
Nagasaki International University, Japan |
|
Prof. Dr. Arne Skerra |
Technical University of Munich, Germany |
|
Prof. Dr. Tianlei Ying |
Fudan University, China |
|
Prof. Dr. Linqi Zhang |
Tsinghua University, China |
|
Prof. Dr. Michael B. Zwick |
The Scripps Research Institute, USA |
The latest Stanford rankings reflect the significant influence and research excellence of the above scientists, who are committed to furthering their knowledge for the benefit of the world.
We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contributions to the scientific progression and development of Antibodies.
